Authors:
ZREIN M
LOUWAGIE J
BOEYKENS H
GOVERS L
HENDRICKX G
BOSMAN F
SABLON E
DEMARQUILLY C
BONIFACE M
SAMAN E
Citation: M. Zrein et al., ASSESSMENT OF A NEW IMMUNOASSAY FOR SEROLOGICAL CONFIRMATION AND DISCRIMINATION OF HUMAN T-CELL LYMPHOTROPIC VIRUS-INFECTIONS, Clinical and diagnostic laboratory immunology, 5(1), 1998, pp. 45-49
Authors:
COCHELARD D
BONIFACE B
DELACOURTE A
DEMARQUILLY C
BONIFACE M
Citation: D. Cochelard et al., DEVELOPMENT OF A NEW SOFTWARE FOR AN INTERACTIVE ANALYSIS OF PARTICLE-SIZE, Drug development and industrial pharmacy, 22(7), 1996, pp. 721-730
Authors:
CHAMBRIN MC
RAVAUX P
JABORSKA A
BEUGNET C
LESTAVEL P
CHOPIN C
BONIFACE M
Citation: Mc. Chambrin et al., INTRODUCTION OF KNOWLEDGE BASES IN PATIENTS DATA MANAGEMENT-SYSTEM - ROLE OF THE USER-INTERFACE, International journal of clinical monitoring and computing, 12(1), 1995, pp. 11-16
Authors:
HOBER D
AJANA F
BONIFACE M
ESTRADA R
LOBERT PE
SARTIAUX C
MOUTON Y
WATTRE P
MANIEZMONTREUIL M
Citation: D. Hober et al., SOLUBLE CD23 IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTED PATIENTS, Microbiology and immunology, 37(5), 1993, pp. 383-390
Authors:
HOBER D
AJANA F
PETIT MC
SARTIAUX C
BONIFACE M
CAILLAUX M
MOUTON Y
WATTRE P
MANIEZMONTREUIL M
Citation: D. Hober et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND TUMOR-NECROSIS-FACTOR-ALPHA IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) TYPE-1INFECTION, Microbiology and immunology, 37(10), 1993, pp. 785-792